 |
Commercial
Scale
Antitubercular
Pyrazinamide
Isoniazid
Rifampicin
Antimalarial
Artesunate
Arteether
Artemether
Dihydroartemisinin
Macrolides
Azithromycin
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin oxime (intermediate)
Erythromycin phosphate
Erythromycin propionate
Erythromycin stearate
Roxithromycin
Antihypertensive
Lisinopril dihydrate
Losartan potassium
Antiepileptic
Sodium valproate
Valproic acid
Antiosteoporotic
Alendronate sodium
Zoledronic acid
Sedative, Hypnotic
Zopiclone
Antidepressant
Venlafaxine hydrochloride
Antihistaminic
Cetirizine dihydrochloride
Antithrombotic
Clopidogrel bisulphate
Pilot Plant Scale
Carvedilol
Clarithromycin
Pioglitazone hydrochloride
Rosiglitazone maleate
Valsartan
R & D Scale
Lumefantrine
Pamidronate disodium
Perindopril erbumine
Zolpidem tartrate
Development
Benazepril hydrochloride
Candesartan
Desvenlafaxine
Glipizide
Irbesartan
Levocetirizine
Ramipril
Rifabutin
Rifapentine
Risedronic acid
Telmisartan
Product
under patent offered only
for exempted research, clinical
and
development purposes.
Only non-
infrining products
and processes
are offered, subject to
patent status
verification by client. |
Services
- Custom
Syntheses
- Contract
Manufacturing
- FTE
Research
- Analytical
Support
- Intermediates
& APIs
-
Building Blocks
|
|
|
New
Committee of Administration at PHARMEXCIL
We
are pleased to inform that in
the 3rd Annual General Meeting
of PHARMEXCIL, held on the 28th
November 2007,
Mr. Smitesh C Shah, Chairman & Managing Director
of Calyx Chemicals & Pharmaceuticals Ltd., Mumbai
has been elected Vice Chairman of
the Council and Mr. Venkat Jasti,
Managing Director of Suven Life
Sciences Limited, Hyderabad has been elected
as the Chairman of the Council for the years 2007-08 and
2008-09.
Other
elected members of the Council are as follows: read
here
|
|
Calyx at CPhI India 2007, Mumbai
We received an overwhelming response during the recent CPhI
India 2007 held
at the Bombay Exhibition Center
at Goregaon, Mumbai. We sincerely thank
all our customers, suppliers and visitors
who took the time out in meeting with
us during 25 – 27 November, 2007.
|
|
|
Excerpts
from the speech delivered by Mr. Smitesh Shah – CMD of
Calyx, at the Inauguration ceremony of CPhI India 2007 on the
25th November 2007
India
has
long been known for the unity in diversity.
Today, the world’s largest democracy has
come to the forefront as a
global resource for industry and services. Its pool of
technical skill, its base of English speaking
populace with an increasing disposable income and its
burgeoning market have all combined to enable India emerge
a viable partner to Global industry.
Investment
opportunities in India are today
perhaps at a peak. Supported by
India’s natural strengths, the country
offers investment opportunities in excess
of US 500 billion in diverse
sectors over the next five years. The government
of India is committed to enabling foreign
investors discover India as a partner- with
whom they can work in synergy
to achieve their objectives of growth and
profitability.
| Welcome
to India and CPhI.
Rich
and resplendent with a
repertoire of knowledge
and character, Dr. Venkateswarlu
nurtures and tends the budding greens (Indian industry)
as they bloom. He is our unshakable pillar the “Science
Czar”.
About CPhI and its organizers.
There
are several ingredients that go into a winning business
including a great idea, a great team, great passion,
and great leadership. All are important, but great passion
can be the fire that helps fuel
the success. They are our catalysts.
Thanks to CMP and its team.
Read
the full speech
|
 |
|
|
| Winners
of Raffle
We had organized 2 raffles,
one on the 25th November and second on the 26th November 2007
during the CPhI India 2007 event and are pleased to announce
the winners.
|
|
| Mr.
Suresh Kumar Mogra - Winner of the Digital Camera |
Ms.
Parisa Zandi - Winner of the Swarovski Crystal |
|
|
|
|
|
|
|
Disclaimer:
"The information in this e-mail and any attachments is
confidential and may be legally privileged. It is intended solely
for the addressee or addressees. If you are not an intended recipient,
please delete the message and any attachments and
notify the sender of misdelivery. Any use or disclosure of the
contents of either is unauthorized and may be
unlawful. All liability for viruses is excluded to the
fullest extent permitted by law. Any views expressed
in this message are those of the individual sender, except where
the sender states them, with requisite authority, to be
those of the specific Calyx company." |
| To
unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com
|
 |
|
